Thursday, January 26, 2023

State of Pharma Conference: Save the DATE!

The State of Pharma (SOP) conference will provide a premier interdisciplinary platform for researchers, practitioners, and representatives from governing bodies to present and discuss the most recent innovations, trends, concerns and practical challenges impacting the pharmaceutical industry at this very moment.


From decision-making regulators actively shaping the future of the industry, to business leaders at the forefront of innovation - this is the most crucial platform for those looking to navigate, and learn directly from industry leaders.


Secure your seat today to avoid missing out and stay tuned for our next announcement to get updates on the full lineup of speakers and agenda!

The final agenda for The State of Pharma has been released and we're excited to be bringing you a day-long program containing in-depth discussions on a wide range of topics related to the pharmaceutical industry. 

 

On May 11th, we will address current challenges and potential solutions within the industry and touch upon the areas of regulation, innovation, and much, much more. 

View the full agenda today. 

Amanda McFarland specializes in the creation and implementation of risk management programs and developing risk-based strategies for use in clinical and commercial settings. Amanda is an active member of the Parenteral Drug Association (PDA), co-chair of the PDA ANSI standard on QRM in aseptic processing, a member of the PDA Regulatory Affairs and Quality Advisory Board, an instructor at PDA -TRI on quality risk management and a member of the Kilmer Regulatory Innovation team.

We are inviting a limited number of organizations to join as Sponsors of the event. For more information or to express an interest please reach out to info@aaps.ca.

TICKETS

      BUY NOW      

SPONSOR

      EMAIL US      
Facebook  Instagram  LinkedIn  Twitter  Web  YouTube

No comments:

Post a Comment